Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
peer of
competitor of
Metrics
marketSTOCKS
msh_idCOM:MINDSETPHARMA
localeus
websitehttps://mindsetpharma.com
ipo_date2020-12-23
primary_stock_msh_idCNQ:MSET
source_refeebda91e-e09c-4c74-8dd1-9d214714d569
products_or_servicesDevelopment of a new class of agonists for psychiatric and neurological disorders.
Canada